2025年全球扁平疣治疗市场报告

预计未来几年睫状体平坦部炎治疗市场规模将强劲成长。 2029年，该市场规模将成长至9,204.8亿美元，复合年增长率为7.7%。预测期内的预期增长归因于生物疗法的普及、自体免疫疾病盛行率的上升、对儿童眼科护理的日益重视、医疗保险覆盖范围的扩大以及对个性化治疗方法日益增长的需求。预计在此期间的主要趋势包括转向类固醇缓释治疗方法、将远距眼科技术融入患者管理、长效药物植入的开发、生物相似药在偏好中的应用以及对联合治疗策略的日益青睐。

鳞状蜂窝性组织炎盛行率的不断上升预计将推动睫状体平坦部炎治疗市场的成长。鳞状蜂窝性组织炎是一种特发性中间葡萄膜炎，可导致玻璃体和周边视网膜发炎，最常见于 15 至 40 岁的人。盛行率的上升与人们所认识的提高和诊断技术的进步有关，从而可以更早、更准确地发现。鳞状蜂窝性组织炎的治疗对于控制眼部发炎、保护视力和预防严重併发症至关重要。这些治疗方法包括皮质类固醇和免疫抑制剂，有助于长期眼部健康和改善生活品质。例如，根据美国医学杂誌《Mega Journal of Case Reports》于 2025 年 2 月发表的病例报告，中间葡萄膜炎的发生率为每 100,000 人口 1.4 至 2 例，其中副鳞状蜂窝性组织炎占这些病例的 70%。发病率的增加促进了治疗市场的扩大。

睫状体平坦部炎治疗领域的公司正专注于开发包括双特异性抗体在内的先进治疗方法，以改善发炎控制并减少全身副作用。双特异性抗体旨在同时结合两种不同的抗原，从而实现更有针对性和更有效的治疗。 2023 年 10 月，美国生物技术公司基因泰克 (Genentech) 的 Vabysmo (faricimab-svoa) 获得 FDA 批准，用于治疗视网膜静脉阻塞，领先该药物已核准用于治疗老龄化黄斑部病变和糖尿病性黄斑部水肿。 Vabysmo 是首个核准用于眼科的双特异性抗体，同时核准血管生成素 2 (Ang-2) 和血管内皮生长因子 A (VEGF-A)。这种双重作用方法有助于控制发炎和血管渗漏，目前正在研究用于治疗中间葡萄膜炎，包括睫状体平坦部炎，这种疾病的视网膜週边持续性发炎需要有针对性的干预。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球睫状体扁平苔癣治疗：PESTEL 分析（政治、社会、技术、环境、法律、驱动因素和限制因素）
• 最终用途产业分析
• 全球扁平疣治疗市场：成长率分析
• 全球扁平疣治疗市场表现：规模与成长，2019-2024 年
• 全球扁平疣治疗市场预测：规模与成长，2024-2029 年，2034 年
• 全球睫状体扁平苔癣治疗：总目标市场（TAM）

第六章市场区隔

• 全球扁平疣治疗市场（依治疗方法、绩效及预测），2019-2024 年、2024-2029 年、2034 年
• 皮质类固醇
• 非类固醇消炎剂（NSAID）
• 外科手术
• 冷冻疗法
• 免疫调节疗法
• 其他治疗方法
• 全球睫状体扁平苔癣治疗市场（依诊断、表现及预测），2019-2024 年、2024-2029 年、2034 年
• 血液检查
• X射线
• 磁振造影（MRI）
• 其他诊断
• 全球睫状体扁平苔癣治疗市场：依给药途径、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 口服
• 静脉
• 其他给药途径
• 全球睫状体扁平苔癣治疗市场：依通路、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 医院药房
• 零售药局
• 网路药局
• 全球扁平疣治疗市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
• 诊所
• 医院
• 其他最终用户
• 全球睫状体扁平苔癣治疗市场，依皮质类固醇类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 局部固醇
• 眼周注射皮质类固醇
• 玻璃体内皮质类固醇植入
• 全身性皮质类固醇
• 全球扁平疣治疗市场按非类固醇消炎剂（NSAID）类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 口服非类固醇消炎剂（NSAID）
• 局部非类固醇消炎剂（NSAID）
• 注射非类固醇消炎剂（NSAID）
• 全球睫状体扁平苔癣治疗市场，依手术类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 玻璃体切除手术
• 白内障手术
• 青光眼手术
• 全球睫状体扁平苔癣治疗市场冷冻疗法细分市场（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
• 经巩膜冷冻疗法
• 体内冷冻疗法
• 全球睫状体扁平苔癣治疗市场按免疫调节疗法类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
• 抗代谢药
• Calcineurin抑制剂
• 生物製药
• 全球睫状体扁平苔癣治疗市场，依其他治疗方法细分，按类型、绩效和预测，2019-2024 年、2024-2029 年、2034 年
• 抗生素
• 抗病毒药物
• 雷射治疗

第七章 区域和国家分析

• 全球扁平疣治疗市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球扁平疣治疗市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 睫状体扁平苔癣治疗市场：竞争格局
• 睫状体扁平苔癣治疗市场：公司简介
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Novartis AG
• EyePoint Pharmaceuticals Inc.
• Medtronic plc
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Quantum Cryogenics Ltd.
• Zimmer MedizinSysteme GmbH
• Sun Pharmaceutical Industries Ltd.
• Hologic Inc.
• Aurobindo Pharma Limited
• Santen Pharmaceutical Co. Ltd.
• CooperSurgical Inc.
• AtriCure Inc.
• Alimera Sciences Inc.
• Clearside Biomedical Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年睫状体扁平苔癣治疗市场：提供新机会的国家
• 2029 年睫状体扁平苔癣治疗市场：细分领域带来新机会
• 2029 年睫状体扁平苔癣治疗市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Pars planitis treatment involves both medical and surgical approaches designed to manage this chronic form of intermediate uveitis, which affects the pars plana region of the eye and may lead to inflammation and potential vision loss. The main objective of treatment is to control ocular inflammation, prevent complications such as macular edema or retinal detachment, and maintain visual function.

The primary treatment options for pars planitis include corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), surgical procedures, cryotherapy, immunomodulatory therapies, and others. Corticosteroids are anti-inflammatory drugs that mimic adrenal gland hormones to reduce swelling, suppress immune activity, and treat inflammation-related conditions. Diagnostic methods include blood tests, X-rays, magnetic resonance imaging (MRI), and others, with treatments administered via oral, intravenous, and other routes. These treatments are distributed through various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by a range of end users including hospitals, clinics, and other healthcare facilities.

The pars planitis treatment market research report is one of a series of new reports from The Business Research Company that provides pars planitis treatment market statistics, including the pars planitis treatment industry's global market size, regional shares, competitors with an pars planitis treatment market share, detailed pars planitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pars planitis treatment industry. This pars planitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pars planitis treatment market size has grown strongly in recent years. It will grow from $632.88 billion in 2024 to $683.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth during the historic period can be attributed to increased awareness of autoimmune eye disorders, a rising incidence of uveitis in pediatric populations, improved access to ophthalmic care, broader use of immunosuppressive therapies, and heightened patient awareness regarding the importance of early intervention.

The pars planitis treatment market size is expected to see strong growth in the next few years. It will grow to $920.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth anticipated in the forecast period can be attributed to the increasing adoption of biologic therapies, a rising prevalence of autoimmune diseases, heightened emphasis on pediatric eye care, broader health insurance coverage, and growing demand for personalized treatment approaches. Key trends expected during this period include a shift toward steroid-sparing treatment options, the integration of teleophthalmology in patient management, the development of long-acting drug implants, the use of biosimilars in therapy, and a rising preference for combination treatment strategies.

The rising prevalence of pars planitis is expected to drive the growth of the pars planitis treatment market. Pars planitis is an idiopathic type of intermediate uveitis that causes inflammation in the vitreous and peripheral retina, most commonly affecting people between the ages of 15 and 40. The increase in prevalence is linked to improved awareness and advancements in diagnostic technology, allowing for earlier and more accurate detection. Treatments for pars planitis are essential for managing ocular inflammation, which helps preserve vision and prevent serious complications. These therapies, which include corticosteroids and immunosuppressants, contribute to better long-term eye health and quality of life. As an example, a case report published in February 2025 by the Mega Journal of Case Reports, a U.S.-based medical journal, noted that intermediate uveitis occurs at a rate of 1.4 to 2 cases per 100,000 people, with pars planitis making up 70% of those cases. This increasing occurrence is contributing to the expansion of the treatment market.

Companies in the pars planitis treatment space are focusing on developing advanced therapies, including bispecific antibodies, to improve inflammation control and reduce systemic side effects. Bispecific antibodies are engineered to bind to two different antigens at once, allowing for more targeted and effective treatment. In October 2023, Genentech Inc., a biotechnology company based in the U.S., received FDA approval for Vabysmo (faricimab-svoa) for treating retinal vein occlusion, in addition to its earlier approvals for age-related macular degeneration and diabetic macular edema. Vabysmo is the first bispecific antibody approved for ophthalmic use, targeting both Angiopoietin-2 (Ang-2) and vascular endothelial growth factor A (VEGF-A). This dual-action approach helps control inflammation and vascular leakage and is being investigated for treating intermediate uveitis, including pars planitis, where persistent inflammation in the retinal periphery requires precise intervention.

In March 2022, Bausch + Lomb, a healthcare company headquartered in Canada, entered into a partnership with Clearside Biomedical Inc. to commercialize XIPERE in the U.S. for treating macular edema linked to uveitis. The goal of the partnership is to broaden access to XIPERE, which is the first FDA-approved therapy administered via suprachoroidal injection. This delivery method offers a targeted and effective option for the estimated 300,000 Americans affected by uveitis. Clearside Biomedical Inc., based in the U.S., contributes to pars planitis treatment through its involvement with XIPERE.

Major players in the pars planitis treatment market are Johnson & Johnson, Merck & Co Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Novartis AG, EyePoint Pharmaceuticals Inc., Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Quantum Cryogenics Ltd., Zimmer MedizinSysteme GmbH, Sun Pharmaceutical Industries Ltd., Hologic Inc., Aurobindo Pharma Limited, Santen Pharmaceutical Co. Ltd., CooperSurgical Inc., AtriCure Inc., Alimera Sciences Inc., and Clearside Biomedical Inc.

North America was the largest region in the pars planitis treatment market in 2024. The regions covered in pars planitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pars planitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pars planitis treatment market consists of revenues earned by entities by providing services such as diagnosis, pharmacological therapies, surgical interventions, and supportive care management. The market value includes the value of related goods sold by the service provider or included within the service offering. The pars planitis treatment market also includes sales of immunosuppressants, intraocular steroid implants, surgical equipment, and diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pars Planitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pars planitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pars planitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pars planitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Corticosteroid; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Surgery; Cryotherapy; Immunomodulatory Therapy; Other Treatments
• 2) By Diagnosis: Blood Tests; X-ray; Magnetic Resonance Imaging (MRI); Other Diagnosis
• 3) By Route Of Administration: Oral; Intravenous; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 5) By End-User: Clinic; Hospital; Other End-Users
• Subsegments:
• 1) By Corticosteroid: Topical Corticosteroids; Periocular Corticosteroid Injections; Intravitreal Corticosteroid Implants; Systemic Corticosteroids
• 2) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Injectable Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• 3) By Surgery: Pars Plana Vitrectomy; Cataract Surgery; Glaucoma Surgery
• 4) By Cryotherapy: Trans-scleral Cryotherapy; Endocryotherapy
• 5) By Immunomodulatory Therapy: Antimetabolites; Calcineurin Inhibitors; Biologic Agents
• 6) By Other Treatments: Antibiotics; Antivirals; Laser therapy
• Companies Mentioned: Johnson & Johnson; Merck & Co Inc.; AbbVie Inc.; Bayer AG; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pars Planitis Treatment Market Characteristics

3. Pars Planitis Treatment Market Trends And Strategies

4. Pars Planitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pars Planitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pars Planitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pars Planitis Treatment Market Growth Rate Analysis
• 5.4. Global Pars Planitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pars Planitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pars Planitis Treatment Total Addressable Market (TAM)

6. Pars Planitis Treatment Market Segmentation

• 6.1. Global Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroid
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Surgery
• Cryotherapy
• Immunomodulatory Therapy
• Other Treatments
• 6.2. Global Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests
• X-ray
• Magnetic Resonance Imaging (MRI)
• Other Diagnosis
• 6.3. Global Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Other Routes Of Administration
• 6.4. Global Pars Planitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.5. Global Pars Planitis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinic
• Hospital
• Other End-Users
• 6.6. Global Pars Planitis Treatment Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Corticosteroids
• Periocular Corticosteroid Injections
• Intravitreal Corticosteroid Implants
• Systemic Corticosteroids
• 6.7. Global Pars Planitis Treatment Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Injectable Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• 6.8. Global Pars Planitis Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pars Plana Vitrectomy
• Cataract Surgery
• Glaucoma Surgery
• 6.9. Global Pars Planitis Treatment Market, Sub-Segmentation Of Cryotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Trans-scleral Cryotherapy
• Endocryotherapy
• 6.10. Global Pars Planitis Treatment Market, Sub-Segmentation Of Immunomodulatory Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antimetabolites
• Calcineurin Inhibitors
• Biologic Agents
• 6.11. Global Pars Planitis Treatment Market, Sub-Segmentation Of Other Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antivirals
• Laser therapy

7. Pars Planitis Treatment Market Regional And Country Analysis

• 7.1. Global Pars Planitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pars Planitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pars Planitis Treatment Market

• 8.1. Asia-Pacific Pars Planitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pars Planitis Treatment Market

• 9.1. China Pars Planitis Treatment Market Overview
• 9.2. China Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pars Planitis Treatment Market

• 10.1. India Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pars Planitis Treatment Market

• 11.1. Japan Pars Planitis Treatment Market Overview
• 11.2. Japan Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pars Planitis Treatment Market

• 12.1. Australia Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pars Planitis Treatment Market

• 13.1. Indonesia Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pars Planitis Treatment Market

• 14.1. South Korea Pars Planitis Treatment Market Overview
• 14.2. South Korea Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pars Planitis Treatment Market

• 15.1. Western Europe Pars Planitis Treatment Market Overview
• 15.2. Western Europe Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pars Planitis Treatment Market

• 16.1. UK Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pars Planitis Treatment Market

• 17.1. Germany Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pars Planitis Treatment Market

• 18.1. France Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pars Planitis Treatment Market

• 19.1. Italy Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pars Planitis Treatment Market

• 20.1. Spain Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pars Planitis Treatment Market

• 21.1. Eastern Europe Pars Planitis Treatment Market Overview
• 21.2. Eastern Europe Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pars Planitis Treatment Market

• 22.1. Russia Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pars Planitis Treatment Market

• 23.1. North America Pars Planitis Treatment Market Overview
• 23.2. North America Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pars Planitis Treatment Market

• 24.1. USA Pars Planitis Treatment Market Overview
• 24.2. USA Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pars Planitis Treatment Market

• 25.1. Canada Pars Planitis Treatment Market Overview
• 25.2. Canada Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pars Planitis Treatment Market

• 26.1. South America Pars Planitis Treatment Market Overview
• 26.2. South America Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pars Planitis Treatment Market

• 27.1. Brazil Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pars Planitis Treatment Market

• 28.1. Middle East Pars Planitis Treatment Market Overview
• 28.2. Middle East Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pars Planitis Treatment Market

• 29.1. Africa Pars Planitis Treatment Market Overview
• 29.2. Africa Pars Planitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pars Planitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pars Planitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pars Planitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Pars Planitis Treatment Market Competitive Landscape
• 30.2. Pars Planitis Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Pars Planitis Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. EyePoint Pharmaceuticals Inc.
• 31.3. Medtronic plc
• 31.4. Eli Lilly and Company
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Quantum Cryogenics Ltd.
• 31.7. Zimmer MedizinSysteme GmbH
• 31.8. Sun Pharmaceutical Industries Ltd.
• 31.9. Hologic Inc.
• 31.10. Aurobindo Pharma Limited
• 31.11. Santen Pharmaceutical Co. Ltd.
• 31.12. CooperSurgical Inc.
• 31.13. AtriCure Inc.
• 31.14. Alimera Sciences Inc.
• 31.15. Clearside Biomedical Inc.

32. Global Pars Planitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pars Planitis Treatment Market

34. Recent Developments In The Pars Planitis Treatment Market

35. Pars Planitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Pars Planitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pars Planitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pars Planitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer